Clinical study on the effect and safety of Plum blossom needle combined with channel palpation method for Electrophysiologl Vascular Ultrasound Images and Neurogenic Inflammatory Factors in patients on stage I of shoulder hand syndrome (SHS) after cerebral stroke

Clinical study on the effect and safety of Plum blossom needle combined with channel palpation method for Electrophysiology, Vascular Ultrasound Images and Neurogenic Inflammatory Factors in patients on stage I of shoulder hand syndrome (SHS) after cerebral stroke

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400080221

Enrollment

Unknown

Registered

2024-01-24

Start date

2024-02-15

Completion date

Unknown

Last updated

2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder hand syndrome (SHS) after stroke

Interventions

Sham controlled group:Sham plum blossom needle treatment

Non smoke group:Non smoke plum blossom needle treatment

Smoke group:Treatment with smoke plum blossom needle

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 40-80 who meet the diagnosis of cerebrovascular disease and SHS stage I; 2. All confirmed by cranial CT or MRI scans; 3. The first onset of the disease or a history of stroke without any sequelae; 4. Clear awareness, stable vital signs, and cooperation with treatment; 5. Muscle strength of the affected upper limb = level 2, muscle tone = level 2 (modified Ashworth Spasm Scale (MAS)); 6. During the trial, only routine medication and rehabilitation treatment were received after stroke, and those who did not take anti spasmodic medication before treatment; 7. Voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Cerebrovascular diseases other than stroke; 2. Patients with abnormal pain threshold caused by lesions in thalamus; 3. Patients with other serious internal diseases; 4. Patients with serious emotional disorders after stroke; 5. Patients with dislocation and subluxation of shoulder joint; 6. Patients with peri-arthritis of shoulder and local soft tissue injury with serious activities have been diagnosed before stroke; 7. Intolerant of treatment.

Design outcomes

Primary

Measure	Time frame
Heart Rate Variability;	—

Secondary

Measure	Time frame
Neurogenic inflammatory factors;Middle venous blood flow indicators;	—

Countries

China

Contacts

Public ContactMeng Xiaonan

Beijing Huguosi Traditional Chinese Medicine Hospital, affiliated to Beijing University of Chinese Medicine

mengxiaonan.cn@gmail.com+86 138 1098 8685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026